Regulations and Regulatory Advocacy
On April 8, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2022 proposed rule for the skilled nursing facility (SNF) prospective payment system (PPS). Comments on the proposed rule are due to CMS by June 7. The final rule is expected around Aug. 1 and will take…
On April 7, the Centers for Medicare & Medicaid Services (CMS) issued its fiscal year (FY) 2022 proposed rule for the inpatient rehabilitation facility (IRF) prospective payment system (PPS). Comments on the rule are due to CMS by June 7. The final rule is expected around Aug. 1 and will take…
The Food and Drug Administration today revoked its emergency use authorization for the COVID-19 monoclonal antibody therapy bamlanivimab when administered alone.
The Centers for Medicare & Medicaid Services (CMS) April 8 issued its fiscal year (FY) 2022 proposed rule for the skilled nursing facility (SNF) prospective payment system (PPS). The proposed rule would increase SNF payments by 1.3% in FY 2022, with varying updates for hospital-based…
The Centers for Medicare & Medicaid Services (CMS) April 7 issued its fiscal year (FY) 2022 proposed rule for the inpatient psychiatric facility (IPF) prospective payment system (PPS). CMS will accept comments on this rule through June 7.
The Department of Health and Human Services through March 26 has reduced by more than 69% its backlog of Medicare appeals at the Administrative Law Judge level, according to a status report the agency provided Friday to a federal court.
The Federal Emergency Management Agency (FEMA) recently updated its policy on “Coronavirus (COVID-19) Pandemic: Medical Care Eligible for Public Assistance
The Department of Health and Human Services postponed for one year, pending judicial review, a final rule that would require the agency to assess periodically each regulation to determine whether it has a significant economic impact on a substantial number of small entities and, if so, determine…
A California state judge granted preliminary approval to a settlement agreement in antitrust litigation alleging Sutter Health used anticompetitive practices in its contracts with a union’s health plans.
The Food and Drug Administration announced an import alert on all alcohol-based hand sanitizers from Mexico, noting that 84% of those it analyzed from April through December 2020 did not comply with FDA regulations and more than half contained toxic ingredients at dangerous levels, including…